Published in:
01-06-2011 | Research Article
Clinical Utility of Positron Emission Tomography/Computed Tomography in Inflammatory Bowel Disease
Authors:
Robert T. Lapp, Bret J. Spier, Scott B. Perlman, Christine J. Jaskowiak, Mark Reichelderfer
Published in:
Molecular Imaging and Biology
|
Issue 3/2011
Login to get access
Abstract
Purpose
The clinical utility of positron emission tomography/computed tomography (PET/CT) in comparison to standard workup in patients with known or suspected inflammatory bowel disease (IBD) is unknown.
Procedures
Clinical data were collected on seven patients with known or suspected IBD undergoing PET/CT. Standard workup included history, physical exam, laboratory tests, colonoscopy and/or cross-sectional imaging. We divided the intestine into five regions [small bowel and four colon (ascending, transverse, descending and rectosigmoid)] and graded relative standard uptake values 0, 1, 2 or 3 by comparison to the liver, using a region-of-interest analysis (0 = no activity, 1 = liver, 2 and 3 = significant inflammation).
Results
In patients 1 and 2, PET/CT demonstrated more activity than we thought clinically present. The other patients avoided unnecessary escalation or initiation of IBD therapy based on PET/CT results. Compared with standard workup, all seven patients had superior results when therapeutic decisions were based on PET/CT.
Conclusions
We found PET/CT to be very useful in diagnosis and management in patients with known or suspected IBD.